Prime Medicine (PRME) Revenue & Revenue Breakdown
Prime Medicine Revenue Highlights
0
Latest Revenue (Q)
$39.31M
Prime Medicine Revenue by Period
Prime Medicine Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -100.00% |
2022-12-31 | $5.21M | 100.00% |
2021-12-31 | - | -100.00% |
2020-12-31 | $5.21M | 100.00% |
2019-12-31 | - | - |
Prime Medicine Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $39.31M | 6551.78% |
2024-03-31 | $591.00K | 100.00% |
2023-12-31 | - | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Prime Medicine Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RPRX | Royalty Pharma | $2.35B | $564.69M |
BEAM | Beam Therapeutics | $377.71M | $14.27M |
CRSP | CRISPR Therapeutics | $370.00M | $602.00K |
DNA | Ginkgo Bioworks | $251.46M | $89.05M |
BPMC | Blueprint Medicines | $249.38M | $128.18M |
NTLA | Intellia Therapeutics | $36.27M | $9.11M |
CRBU | Caribou Biosciences | $34.48M | $3.46M |
RLAY | Relay Therapeutics | $25.55M | - |
VERV | Verve Therapeutics | $11.76M | $6.87M |
IPSC | Century Therapeutics | $2.23M | $791.00K |
LIFE | aTyr Pharma | $353.00K | $235.00K |
EDIT | Editas Medicine | - | - |
PRME | Prime Medicine | - | $39.31M |
SANA | Sana Bio | - | - |
OCEA | Ocean Biomedical | - | - |
RPHM | Reneo Pharmaceuticals | - | - |